The investigators hypothesize that significant exposure to artificial morning bright light (approximately 200 lux of primarily blue light at eye level for thirty minutes daily) as compared to sham bright red light (placebo) will: 1. improve sleep quality 2. improve cognitive scores 3. improve depression scores 4. improve quality of life scores.
Bright light therapy has been shown to improve depression and insomnia in multiple studies. These are common conditions among elders, particularly those residing in long term care environments. Bright light therapy has been inadequately studied in the geriatric population. We will show that a groups of twenty elders can simultaneous be exposed to bright light and that it will result in improvements in multiple realms of behavior and quality of life. Elders will be tested with a number of neuropsychological test batteries prior to exposure to bright light and again at the end of a four week exposure. Some subjects will have daytime and night time activity levels monitored with actigraphy. Cortisol and melatonin levels will be obtained prior to and at the end of the exposure period.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
32
Elders will be engaged in an activity period which will focus their attention in the direction of bright light, thus ensuring viewing the light source for a daily exposure of thirty minutes.
Low level red light should not entrain circadian rhythm and will serve as a placebo control
Masonic Villages
Elizabethtown, Pennsylvania, United States
assessment of cognitive functioning using MicroCog
Time frame: once prior to intervention, once near the end of intervention, once four weeks after intervention
Assessment of mood using the Geriatric Depression Scale
Time frame: once prior to intervention, once near the end of intervention, once four weeks after intervention
assessment of quality of life using the SF-36
Time frame: once prior to intervention, once near the end of intervention, once four weeks after intervention
assessment of sleep quality using the Pittsburgh Sleep Quality Index
Time frame: once prior to intervention, once near the end of intervention, once four weeks after intervention
assessment of mood using the Profile of Moods Survey
Time frame: weekly throughout the duration of the study
assessment of sleep quality using the Epworth Sleepiness Scale
Time frame: weekly throughout the duration of the study
day and nightime activity level (5 subjects per group only) using Actigraphy
Time frame: two weeks prior to light exposure and the second two weeks during light exposure (continuous measurements)
salivary melatonin levels
Time frame: once prior and near the end of light exposure period
salivary cortisol levels
Time frame: once prior and near the end of light exposure period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.